Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroids for HAV-induced Fulminant Hepatic Failure in Children
NCT02375867Phase 4Completed
- Sponsor
- National Liver Institute
- Start
- Jan 2015
- Primary completion
- Aug 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of prednisolone, methylprednisolone injection in fulminant hepatic failure (FHF), sponsored by National Liver Institute. Started Jan 2015; status: completed.
02
Drugs
prednisolonemethylprednisolone injection
03
Conditions
fulminant hepatic failure (FHF)
Beyond the preview
Go deeper on NCT02375867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02375867.